Computer Science - Feb 3
Appointment of first Chief Information Security Officer at The University of Manchester
Appointment of first Chief Information Security Officer at The University of Manchester
Innovation - Feb 3
Manchester leads UK project to assess BECCS' future role in North West industrial cluster
Manchester leads UK project to assess BECCS' future role in North West industrial cluster
Research management - Feb 3
Research projects investigating universal carbon accounting and net-zero concrete win funding
Research projects investigating universal carbon accounting and net-zero concrete win funding
wire
« BACK
Health - Pharmacology - 04.02.2023
Health - Pharmacology - 31.01.2023
Innovation - Pharmacology - 30.01.2023
Health - Pharmacology - 30.01.2023 
Three quarters of UK parents support routine chickenpox vaccine for children
Almost three quarters of UK parents would support a chickenpox vaccine being added to the childhood vaccination schedule, finds new research led by UCL and Keele University. The research team, led by Professor Helen Bedford (UCL Great Ormond Street Institute of Child Health) and Dr Sue Sherman (Keele University), surveyed nearly 600 parents on their attitudes towards a varicella (chickenpox) vaccine, including whether it should be routinely offered to all children, and whether they would be likely to accept it for their child.
Health - Pharmacology - 26.01.2023
Health - Pharmacology - 23.01.2023
Pharmacology - Health - 19.01.2023 
New precision therapy for bile duct cancer extends patients’ lives
A new personalised cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international multicentre trial involving researchers at UCL and University College London Hospitals NHS Trust (UCLH).
Health - Pharmacology - 18.01.2023
Health - Pharmacology - 17.01.2023
Health - Pharmacology - 16.01.2023 
Experimental cancer therapy research continues at Birmingham
New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
Health - Pharmacology - 16.01.2023 
Testing wastewater for Covid-19 and communicable diseases
Wastewater monitoring for levels of Covid-19 in Wales have been expanded to include observation of the levels of communicable diseases and antimicrobial resistance in hospital wastewater.
Health - Pharmacology - 06.01.2023
Health - Pharmacology - 04.01.2023
Computer Science - Pharmacology - 03.01.2023 
Led team wins time on world’s most powerful computer
A UCL-led team of researchers is using the world's first exascale computer to identify a shortlist of potential new drugs for diseases and to better understand how stroke affects the brain. The supercomputer, Frontier, at the Oak Ridge Leadership Computing Facility in Tennessee, US, is the first in the world capable of an exaflop - a billion billion operations a second.
Health - Pharmacology - 03.01.2023
Health - Pharmacology - 31.12.2022
Health - Pharmacology - 29.12.2022
Health - Pharmacology - 26.12.2022
Health - Pharmacology - 21.12.2022
Health - Pharmacology - 15.12.2022
Health - Pharmacology - 15.12.2022
Pharmacology - Health - 15.12.2022
Health - Pharmacology - 14.12.2022
Health - Pharmacology - 12.12.2022 
World-first use of base-edited CAR T-cells to treat resistant leukaemia
A patient with relapsed T-cell leukaemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a 'bench-to-bedside' collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).
Health - Pharmacology - 08.12.2022 
Opinion: China could face a catastrophic COVID surge as it lifts restrictions
Following China's strict zero-COVID strategy, Professor Francois Balloux (UCL Biosciences) warns in The Conversation about the risk of a likely surge in infections as restrictions ease.
Health - Pharmacology - 07.12.2022
Health - Pharmacology - 29.11.2022
Health - Pharmacology - 28.11.2022
Health - Pharmacology - 23.11.2022
Life Sciences - Pharmacology - 22.11.2022 
Sequencing project to unleash the biotechnology potential of single-celled algae
An ambitious plan to sequence the genomes of all known species of euglenoids over the next decade has been launched today.
Health - Pharmacology - 10.11.2022 
Recruitment milestone reached in breast cancer trial
A milestone 3,000 participants have been recruited to a clinical trial led by UCL and UCLH, which is aimed at reducing the number of patients with breast cancer who receive unnecessary chemotherapy.
Pharmacology - 16.09.2022
Health - Pharmacology - 24.08.2022
Health - Pharmacology - 01.08.2022
Health - Pharmacology - 05.07.2022
Health - Pharmacology - 27.06.2022 
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
A major clinical trial, led by experts at the University of Nottingham working in partnership with Universities and NHS hospitals including the University of Manchester , has found that by interrupting the treatment of vulnerable people on long-term immune suppressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.
Pharmacology - Health - 24.06.2022
Health - Pharmacology - 22.06.2022 
COPD patients respond equally well to COVID-19 vaccine
A study which tested the immune response of COPD patients to COVID-19 vaccination has shown they respond in a similar way to healthy people.
Pharmacology - 21.06.2022
Health - Pharmacology - 17.06.2022
Health - Pharmacology - 16.06.2022
Health - Pharmacology - 16.06.2022
Pharmacology - Health - 15.06.2022 
UK researchers pioneer new virtual treatment for PTSD
Researchers at Cardiff University have pioneered a new form of virtual treatment for people with post-traumatic stress disorder (PTSD).
Pharmacology - 07.06.2022 
COVID-19 and Brexit ’caused sharp rise in copycat ecstasy’
A new study has highlighted the apparent effect of Brexit and the pandemic on the trade in the illegal party drug ecstasy (MDMA). Researchers from The Loop, a UK drug checking charity, found almost half (45%) of substances sold as MDMA at English festivals last year contained none - and instead contained other drugs such as caffeine or cathinones.
Pharmacology - Health - 06.06.2022
Pharmacology - Health - 26.05.2022
Pharmacology - Health - 25.05.2022 
University spinout in major partnership to commercialize treatment for invasive aspergillosis
F2G, a University of Manchester spinout company, is to partner a major Japanese pharmaceutical company in the commercialisation of a novel antifungal treatment it developed for invasive aspergillosis and other rare mould infections.
Health - Pharmacology - 15.05.2022 
Robotic surgery is safer and improves patient recovery time
Robot-assisted surgery used to perform bladder cancer removal enables patients to recover far more quickly and spend significantly (20 per cent) less time in hospital, concludes a first-of-its kind clinical trial led by scientists at UCL and the University of Sheffield.
Pharmacology - Health - 12.05.2022
Health - Pharmacology - 12.05.2022 
New report outlines vision for safe, effective and accessible medicines in pregnancy
A UK-first report into the state of pregnancy medicine, which was co-commissioned by Professor Anna David (UCL EGA Institute for Women's Health), has proposed a clear roadmap to help reduce the high number of needless newborn deaths and improve maternal health.
Pharmacology
Results 1 - 50 of 571.
Life changing research celebrated on World Cancer Day
The life-changing impact of cancer research done at the University is being celebrated on the first anniversary of the Leeds Cancer Research Centre.
The life-changing impact of cancer research done at the University is being celebrated on the first anniversary of the Leeds Cancer Research Centre.
University of Glasgow to lead international effort to advance cancer care and research
A team of experts from the University of Glasgow will lead a new international effort to improve cancer control and reduce global health inequalities.
A team of experts from the University of Glasgow will lead a new international effort to improve cancer control and reduce global health inequalities.
Antiverse joins Cardiff Innovations
The biotech start-up Antiverse has joined Cardiff Innovations. Antiverse is striving to engineer the future of drug discovery, with an overarching goal to generate novel therapeutics that can change the course of people's lives.
The biotech start-up Antiverse has joined Cardiff Innovations. Antiverse is striving to engineer the future of drug discovery, with an overarching goal to generate novel therapeutics that can change the course of people's lives.
Almost three quarters of UK parents would support a chickenpox vaccine being added to the childhood vaccination schedule, finds new research led by UCL and Keele University. The research team, led by Professor Helen Bedford (UCL Great Ormond Street Institute of Child Health) and Dr Sue Sherman (Keele University), surveyed nearly 600 parents on their attitudes towards a varicella (chickenpox) vaccine, including whether it should be routinely offered to all children, and whether they would be likely to accept it for their child.
£2.2m for Glasgow Cancer Centre to help find new treatments
The development of new cancer treatments in Scotland is to receive major funding, providing future hope for people diagnosed with the disease.
The development of new cancer treatments in Scotland is to receive major funding, providing future hope for people diagnosed with the disease.
Major funding for Manchester will help find new cancer treatments
The search for new cancer treatments in Manchester is to receive a major funding investment of up to £3m, providing future hope for people diagnosed with the disease.
The search for new cancer treatments in Manchester is to receive a major funding investment of up to £3m, providing future hope for people diagnosed with the disease.
A new personalised cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international multicentre trial involving researchers at UCL and University College London Hospitals NHS Trust (UCLH).
Imperial-CNRS-Lille project to ’fast-track’ treatments for metabolic diseases
Imperial, France's National Centre for Scientific Research (CNRS) and the University of Lille are setting up a major project into metabolic diseases. Diseases linked with metabolism, such as diabetes, high blood pressure (hypertension) and obesity affect millions of people around the world. This new collaboration will aim to 'fast-track' treatments for these conditions.
Imperial, France's National Centre for Scientific Research (CNRS) and the University of Lille are setting up a major project into metabolic diseases. Diseases linked with metabolism, such as diabetes, high blood pressure (hypertension) and obesity affect millions of people around the world. This new collaboration will aim to 'fast-track' treatments for these conditions.
New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
Wastewater monitoring for levels of Covid-19 in Wales have been expanded to include observation of the levels of communicable diseases and antimicrobial resistance in hospital wastewater.
New simple method to diagnose adrenal insufficiency shaping way for improving the health of those affected
A new study led by the University of Sheffield in partnership with Sheffield Teaching Hospitals NHS Foundation Trust using saliva rather than blood to test for adrenal insufficiency offers significant improvements for screening patients The research shows how the new testing methods can make diagnosis more efficient at reduced cost The tests are being implemented in clinical practices in Sheffield and will be rolled out across the NHS A study in
A new study led by the University of Sheffield in partnership with Sheffield Teaching Hospitals NHS Foundation Trust using saliva rather than blood to test for adrenal insufficiency offers significant improvements for screening patients The research shows how the new testing methods can make diagnosis more efficient at reduced cost The tests are being implemented in clinical practices in Sheffield and will be rolled out across the NHS A study in
First UK proton beam therapy trial for breast cancer launches
Cambridge researchers are jointly leading the first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer.
Cambridge researchers are jointly leading the first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer.
A UCL-led team of researchers is using the world's first exascale computer to identify a shortlist of potential new drugs for diseases and to better understand how stroke affects the brain. The supercomputer, Frontier, at the Oak Ridge Leadership Computing Facility in Tennessee, US, is the first in the world capable of an exaflop - a billion billion operations a second.
Trial of innovative CAR-T blood cancer treatment expanded
A clinical trial of a personalised therapy for blood cancer, led by researchers at UCL and University College London Hospitals, has been expanded enabling new groups of patients with a wider range of blood cancers to now receive the treatment. The new type of CAR T-cell therapy - where a patient's own immune system is 'reprogrammed' in order to fight their cancer - has already been shown to have promise for adult patients with a type of blood cancer called relapsed B-cell acute lymphoblastic leukaemia (B-ALL).
A clinical trial of a personalised therapy for blood cancer, led by researchers at UCL and University College London Hospitals, has been expanded enabling new groups of patients with a wider range of blood cancers to now receive the treatment. The new type of CAR T-cell therapy - where a patient's own immune system is 'reprogrammed' in order to fight their cancer - has already been shown to have promise for adult patients with a type of blood cancer called relapsed B-cell acute lymphoblastic leukaemia (B-ALL).
6 amazing scientific achievements at Imperial in 2022
From exploring magic mushrooms to answering COVID-19 questions, here are some of Imperial's biggest findings this year: Psilocybin "opens up" the brains of people with depression Psilocybin, the psychedelic component of magic mushrooms, was shown in April to increase brain connectivity in people with depression.
From exploring magic mushrooms to answering COVID-19 questions, here are some of Imperial's biggest findings this year: Psilocybin "opens up" the brains of people with depression Psilocybin, the psychedelic component of magic mushrooms, was shown in April to increase brain connectivity in people with depression.
What Imperial research taught us about COVID-19 in 2022
From increased understanding of immunity to analysing the success of vaccines, we look back at what Imperial taught us about COVID-19 in 2022. Omicron infection doesn't boost immunity much A study published in March in the journal Science found that in triple-vaccinated people infected for the first time, Omicron infection boosted immunity against previous variants (such as alpha, delta, and the original strain) but less so against Omicron.
From increased understanding of immunity to analysing the success of vaccines, we look back at what Imperial taught us about COVID-19 in 2022. Omicron infection doesn't boost immunity much A study published in March in the journal Science found that in triple-vaccinated people infected for the first time, Omicron infection boosted immunity against previous variants (such as alpha, delta, and the original strain) but less so against Omicron.
University of Glasgow cancer experts to receive £1.7m from Cancer Research UK
University of Glasgow scientists are to receive £1.7m from Cancer Research UK to investigate both the root causes of cancer and how treatments can be improved. Professor Stephen Tait, of the Cancer Research UK Beatson Institute and the Glasgow University School of Cancer Sciences, will receive £1,646,832 to investigate what causes cancer cells to grow out of control and form tumours.
University of Glasgow scientists are to receive £1.7m from Cancer Research UK to investigate both the root causes of cancer and how treatments can be improved. Professor Stephen Tait, of the Cancer Research UK Beatson Institute and the Glasgow University School of Cancer Sciences, will receive £1,646,832 to investigate what causes cancer cells to grow out of control and form tumours.
Racism is ’fundamental cause’ of COVID-19 vaccine hesitancy among ethnic minorities
Racism is the 'fundamental cause' of COVID-19 vaccination hesitancy among ethnic minority groups, according to a newly published briefing from the Runnymede Trust and The University of Manchester's Centre on the Dynamics of Ethnicity. During the rollout of the COVID-19 vaccination programme in the UK, explanations for the lower vaccination rates in people from ethnic minority groups focused on differences in the level of concern about side effects and in a lack of trust in the development and efficacy of the vaccine.
Racism is the 'fundamental cause' of COVID-19 vaccination hesitancy among ethnic minority groups, according to a newly published briefing from the Runnymede Trust and The University of Manchester's Centre on the Dynamics of Ethnicity. During the rollout of the COVID-19 vaccination programme in the UK, explanations for the lower vaccination rates in people from ethnic minority groups focused on differences in the level of concern about side effects and in a lack of trust in the development and efficacy of the vaccine.
One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer
One in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it, new research has found.
One in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it, new research has found.
World-first genetic test for babies’ hearing wins major award
A team who led the research for a world-first genetic test that could save the hearing of hundreds of babies each year, has won the New Statesman Positive Impact in Healthcare Award 2022.
A team who led the research for a world-first genetic test that could save the hearing of hundreds of babies each year, has won the New Statesman Positive Impact in Healthcare Award 2022.
A patient with relapsed T-cell leukaemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a 'bench-to-bedside' collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).
Following China's strict zero-COVID strategy, Professor Francois Balloux (UCL Biosciences) warns in The Conversation about the risk of a likely surge in infections as restrictions ease.
Key to supercharging immunotherapy’s ability to stop breast cancer spreading to the lung
Glasgow scientists discover key to supercharging immunotherapy's ability to stop breast cancer spreading to the lung Breast cancer immunotherapy could be more effective if an immune cell that prevents it from working is targeted at the same time, according to new Breast Cancer Now and Secondary1st funded research from the University of Glasgow.
Glasgow scientists discover key to supercharging immunotherapy's ability to stop breast cancer spreading to the lung Breast cancer immunotherapy could be more effective if an immune cell that prevents it from working is targeted at the same time, according to new Breast Cancer Now and Secondary1st funded research from the University of Glasgow.
Multi-million-pound trial will help rapidly find flu treatments this winter
A new national trial, launched today, aims to use pandemic lessons to help quickly find effective treatments for people hospitalised with severe flu.
A new national trial, launched today, aims to use pandemic lessons to help quickly find effective treatments for people hospitalised with severe flu.
Blood thinning drug to treat recovery from severe COVID-19 is not effective
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.
Precision medicine trial opens for rare adult and paedatric cancers
Cancer Research UK, The University of Manchester and Roche Products Ltd ('Roche'), today (Wednesday 23rd), announce that they have opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options.
Cancer Research UK, The University of Manchester and Roche Products Ltd ('Roche'), today (Wednesday 23rd), announce that they have opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options.
An ambitious plan to sequence the genomes of all known species of euglenoids over the next decade has been launched today.
A milestone 3,000 participants have been recruited to a clinical trial led by UCL and UCLH, which is aimed at reducing the number of patients with breast cancer who receive unnecessary chemotherapy.
NHS must learn to love smart IV pumps to avoid drug errors
Hospitals must start using "smart" intravenous (IV) infusion technology to its full potential if they are to prevent dangerous drug errors, University of Manchester researchers have found.
Hospitals must start using "smart" intravenous (IV) infusion technology to its full potential if they are to prevent dangerous drug errors, University of Manchester researchers have found.
Pandemic Sciences Institute formally launched in Oxford
The University of Oxford's Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.
The University of Oxford's Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.
A major clinical trial, led by experts at the University of Nottingham working in partnership with Universities and NHS hospitals including the University of Manchester , has found that by interrupting the treatment of vulnerable people on long-term immune suppressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.
Which patients with advanced prostate cancer will benefit from chemotherapy
Researchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chemotherapy is significantly more effective for some men with advanced prostate cancer than others.
Researchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chemotherapy is significantly more effective for some men with advanced prostate cancer than others.
A study which tested the immune response of COPD patients to COVID-19 vaccination has shown they respond in a similar way to healthy people.
Heart surgery delays will cost lives, warns research
Pandemic has delayed lifesaving treatment for thousands of people with severe aortic stenosis. Our approach does not put the onus on only management or doctors, but creates a joint solution that is easier to implement in practice Feryal Erhun Urgent action is needed to clear the backlog of people with a common heart condition who are waiting for lifesaving treatment, according to published in the journal BMJ Open .
Pandemic has delayed lifesaving treatment for thousands of people with severe aortic stenosis. Our approach does not put the onus on only management or doctors, but creates a joint solution that is easier to implement in practice Feryal Erhun Urgent action is needed to clear the backlog of people with a common heart condition who are waiting for lifesaving treatment, according to published in the journal BMJ Open .
New system that defines Huntington’s Disease will ’revolutionise’ drug trials
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; paving the way for clinical trials of drugs in the earliest stages of HD.
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; paving the way for clinical trials of drugs in the earliest stages of HD.
Researchers in Glasgow to receive £1.9m to tackle late stage cancer syndrome
Scientists at the Cancer Research UK Beatson Institute and the University of Glasgow are to receive £1.9m to explore the causes of a debilitating wasting disease that many people experience in the later stages of cancer. The funding is from Cancer Grand Challenges, a research initiative co-founded by Cancer Research UK and the National Cancer Institute in the US, which aims to encourage the world's leading researchers to tackle the toughest challenges faced by cancer patients.
Scientists at the Cancer Research UK Beatson Institute and the University of Glasgow are to receive £1.9m to explore the causes of a debilitating wasting disease that many people experience in the later stages of cancer. The funding is from Cancer Grand Challenges, a research initiative co-founded by Cancer Research UK and the National Cancer Institute in the US, which aims to encourage the world's leading researchers to tackle the toughest challenges faced by cancer patients.
Researchers at Cardiff University have pioneered a new form of virtual treatment for people with post-traumatic stress disorder (PTSD).
A new study has highlighted the apparent effect of Brexit and the pandemic on the trade in the illegal party drug ecstasy (MDMA). Researchers from The Loop, a UK drug checking charity, found almost half (45%) of substances sold as MDMA at English festivals last year contained none - and instead contained other drugs such as caffeine or cathinones.
Study identifies best treatment for rare childhood cancer
High doses of drug called ifosfamide are the best way to treat a cancer of children which affects bones and soft tissues, compared to three other treatments, according to University of Manchester researchers.
High doses of drug called ifosfamide are the best way to treat a cancer of children which affects bones and soft tissues, compared to three other treatments, according to University of Manchester researchers.
F2G, a University of Manchester spinout company, is to partner a major Japanese pharmaceutical company in the commercialisation of a novel antifungal treatment it developed for invasive aspergillosis and other rare mould infections.
Robot-assisted surgery used to perform bladder cancer removal enables patients to recover far more quickly and spend significantly (20 per cent) less time in hospital, concludes a first-of-its kind clinical trial led by scientists at UCL and the University of Sheffield.
Spotlight on... Professor Jayant S Vaidya
This week Jayant, Professor of Surgery and Oncology at UCL Division of Surgery, shares the story of how he helped to develop a pioneering new treatment for breast cancer, which is featured as a case study in UCL's latest REF submission.
This week Jayant, Professor of Surgery and Oncology at UCL Division of Surgery, shares the story of how he helped to develop a pioneering new treatment for breast cancer, which is featured as a case study in UCL's latest REF submission.
A UK-first report into the state of pregnancy medicine, which was co-commissioned by Professor Anna David (UCL EGA Institute for Women's Health), has proposed a clear roadmap to help reduce the high number of needless newborn deaths and improve maternal health.
Computer Science - Feb 3
Appointment of first Chief Information Security Officer at The University of Manchester
Appointment of first Chief Information Security Officer at The University of Manchester
Innovation - Feb 3
Manchester leads UK project to assess BECCS' future role in North West industrial cluster
Manchester leads UK project to assess BECCS' future role in North West industrial cluster
Research management - Feb 3
Research projects investigating universal carbon accounting and net-zero concrete win funding
Research projects investigating universal carbon accounting and net-zero concrete win funding